Eradication of human immunodeficiency virus from brain reservoirs

被引:0
|
作者
Avindra Nath
机构
[1] National Institutes of Health,Section of Infections of the Nervous System, National Institute of Neurological disorders and Stroke
来源
Journal of NeuroVirology | 2015年 / 21卷
关键词
Compartmentalization; Astrocyte; Microglia; Macrophage; Antiretroviral; Latency;
D O I
暂无
中图分类号
学科分类号
摘要
Isolated cases in which human immunodeficiency virus (HIV) infection was claimed to have been eradicated generated renewed interest in HIV reservoirs in the brain particularly since attempts to reproduce the findings using genetically engineered stem cells and immune- or myeloablation have failed. A clear understanding of the cell types in which the virus resides in the brain, the mechanism of viral persistence, restricted replication and latency, and the turnover rate of the infected cells is critical for us to develop ways to control or get rid of the virus in the brain. The brain has several unique features compared to other reservoirs. There are no resident T cells in the brain; the virus resides in macrophages and astrocytes where the viral infection is non-cytopathic. The virus evolves in the brain and since the turnover rate of these cells is low, the virus has the potential to reside in these cells for several decades and possibly for the life of the individual. This review discusses the HIV reservoirs in the brain, issues related to eradication of the virus from sanctuaries in the brain, and current challenges faced by neuroscientists in finding a cure.
引用
收藏
页码:227 / 234
页数:7
相关论文
共 50 条
  • [21] Human Immunodeficiency Virus and the Central Nervous System
    Mirza, Ayesha
    Rathore, Mobeen H.
    SEMINARS IN PEDIATRIC NEUROLOGY, 2012, 19 (03) : 119 - 123
  • [22] Eradication of HIV from the brain: reasons for pause
    Nath, Avindra
    Clements, Janice E.
    AIDS, 2011, 25 (05) : 577 - 580
  • [23] Novel pathway of human immunodeficiency virus type 1 uptake and release in astrocytes
    Clarke, JN
    Lake, JA
    Burrell, CJ
    Wesselingh, SL
    Gorry, PR
    Li, P
    VIROLOGY, 2006, 348 (01) : 141 - 155
  • [24] The Effect of Latency Reversal Agents on Primary CD8+ T Cells: Implications for Shock and Kill Strategies for Human Immunodeficiency Virus Eradication
    Walker-Sperling, Victoria E.
    Pohlmeyer, Christopher W.
    Tarwater, Patrick M.
    Blankson, Joel N.
    EBIOMEDICINE, 2016, 8 : 217 - 229
  • [25] Impact of fluctuation in frequency of human immunodeficiency virus/simian immunodeficiency virus reactivation during antiretroviral therapy interruption
    Wu, Yuhuang
    Pinkevych, Mykola
    Xu, Zhuang
    Keele, Brandon F.
    Davenport, Miles P.
    Cromer, Deborah
    PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2020, 287 (1933)
  • [26] Host and virus strain dependence in activation of human macrophages by human immunodeficiency virus type 1
    Kazmierczak, Katarzyna
    Potash, Mary Jane
    JOURNAL OF NEUROVIROLOGY, 2007, 13 (05) : 452 - 461
  • [27] Initial therapy for human immunodeficiency virus: Broadening the options
    Sension, M
    HIV CLINICAL TRIALS, 2004, 5 (02): : 99 - 111
  • [28] Microglia in human immunodeficiency virus-associated neurodegeneration
    Garden, GA
    GLIA, 2002, 40 (02) : 240 - 251
  • [29] Complement component 3 and complement factor H protein levels are altered in brain tissues from people with human immunodeficiency virus: A pilot study
    Fields, Jerel Adam
    Swinton, Mary
    Sundermann, Erin E.
    Scrivens, Nicholas
    Vallee, Kaylie-Anna Juliette
    Moore, David J.
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [30] Prevalence of Seizures in Children Infected With Human Immunodeficiency Virus
    Samia, Pauline
    Petersen, Reneva
    Walker, Kathleen G.
    Eley, Brian
    Wilmshurst, Jo M.
    JOURNAL OF CHILD NEUROLOGY, 2013, 28 (03) : 297 - 302